Association of lithocholic acid with skeletal muscle hypertrophy through TGR5-IGF-1 and skeletal muscle mass in chronic liver disease rats and humans
View ORCID ProfileYasuyuki Tamai, View ORCID ProfileAkiko Eguchi, Ryuta Shigefuku, Hiroshi Kitamura, Mina Tempaku, Ryosuke Sugimoto, View ORCID ProfileYoshinao Kobayashi, Motoh Iwasa, Yoshiyuki Takei, Hayato Nakagawa
doi: https://doi.org/10.1101/2022.06.14.22276395
Yasuyuki Tamai
1Department of Gastroenterology and Hepatology, Mie University Graduate School of Medicine
Akiko Eguchi
1Department of Gastroenterology and Hepatology, Mie University Graduate School of Medicine
Ryuta Shigefuku
1Department of Gastroenterology and Hepatology, Mie University Graduate School of Medicine
Hiroshi Kitamura
2Department of Veterinary Medicine, School of Veterinary Medicine, Rakuno Gakuen University
Mina Tempaku
1Department of Gastroenterology and Hepatology, Mie University Graduate School of Medicine
Ryosuke Sugimoto
1Department of Gastroenterology and Hepatology, Mie University Graduate School of Medicine
Yoshinao Kobayashi
3Center for Physical and mental health, Mie University Graduate School of Medicine
Motoh Iwasa
1Department of Gastroenterology and Hepatology, Mie University Graduate School of Medicine
Yoshiyuki Takei
1Department of Gastroenterology and Hepatology, Mie University Graduate School of Medicine
Hayato Nakagawa
1Department of Gastroenterology and Hepatology, Mie University Graduate School of Medicine
Data Availability
All data are included in the manuscript.
Posted June 16, 2022.
Association of lithocholic acid with skeletal muscle hypertrophy through TGR5-IGF-1 and skeletal muscle mass in chronic liver disease rats and humans
Yasuyuki Tamai, Akiko Eguchi, Ryuta Shigefuku, Hiroshi Kitamura, Mina Tempaku, Ryosuke Sugimoto, Yoshinao Kobayashi, Motoh Iwasa, Yoshiyuki Takei, Hayato Nakagawa
medRxiv 2022.06.14.22276395; doi: https://doi.org/10.1101/2022.06.14.22276395
Association of lithocholic acid with skeletal muscle hypertrophy through TGR5-IGF-1 and skeletal muscle mass in chronic liver disease rats and humans
Yasuyuki Tamai, Akiko Eguchi, Ryuta Shigefuku, Hiroshi Kitamura, Mina Tempaku, Ryosuke Sugimoto, Yoshinao Kobayashi, Motoh Iwasa, Yoshiyuki Takei, Hayato Nakagawa
medRxiv 2022.06.14.22276395; doi: https://doi.org/10.1101/2022.06.14.22276395
Subject Area
Subject Areas
- Addiction Medicine (393)
- Allergy and Immunology (705)
- Anesthesia (197)
- Cardiovascular Medicine (2882)
- Dermatology (247)
- Emergency Medicine (432)
- Epidemiology (12622)
- Forensic Medicine (10)
- Gastroenterology (813)
- Genetic and Genomic Medicine (4483)
- Geriatric Medicine (409)
- Health Economics (717)
- Health Informatics (2868)
- Health Policy (1059)
- Hematology (379)
- HIV/AIDS (911)
- Medical Education (418)
- Medical Ethics (115)
- Nephrology (466)
- Neurology (4251)
- Nursing (228)
- Nutrition (622)
- Oncology (2226)
- Ophthalmology (634)
- Orthopedics (255)
- Otolaryngology (323)
- Pain Medicine (270)
- Palliative Medicine (83)
- Pathology (491)
- Pediatrics (1182)
- Primary Care Research (488)
- Public and Global Health (6829)
- Radiology and Imaging (1503)
- Respiratory Medicine (908)
- Rheumatology (431)
- Sports Medicine (376)
- Surgery (476)
- Toxicology (60)
- Transplantation (206)
- Urology (176)